Skip to main content

2025 Midyear Clinical Meeting & Exhibition Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Vincent Englebert T. Sy-siong, BSPharm

Pharmacy Student
Notre Dame of Maryland University

Poster(s):

(3-206) Postmarket Safety Comparison of Sotagliflozin vs. SGLT2 Inhibitors: FDA-Labeled Important & Most Frequent Adverse Reactions vs FAERS Reports

Monday, December 8, 2025
12:00 PM - 1:00 PM